As 2026 unfolds, the market landscape has been anything but static, with two sectors experiencing particularly notable momentum: life sciences and the energy and compute infrastructure underpinning artificial intelligence. Both are seeing significant activity at the small- and mid-cap level, yet understanding individual companies in these fields often demands more than a glance at filings or stock charts. It is against this backdrop that Moody Capital Solutions will host its 2026 Disruptive Growth & Life Sciences Conference on September 9–10 at The Westin New York Grand Central.
The conference is designed to bring together these two dynamic sectors across two tracks and two days, offering investors a rare opportunity to delve into the specifics of companies that are shaping the future. With life sciences continuing to push boundaries in drug development and medical technology, and the explosive growth of AI driving unprecedented demand for energy and computing power, the intersection of these industries is becoming a focal point for investors seeking growth opportunities.
“There are years when a small-cap investor conference is a nice-to-have,” organizers note. “This is not one of them.” The timing of the conference is intentional, as both sectors are at critical junctures. For life sciences, regulatory shifts, breakthrough innovations, and a renewed focus on precision medicine are creating both opportunities and complexities. Meanwhile, the AI boom has triggered a surge in infrastructure investments, from data centers to advanced chip manufacturing, all of which require massive energy inputs. This convergence has sparked interest in companies that provide the backbone for AI, including those in the energy sector that are adapting to meet the growing power needs.
Investors attending the conference will have the chance to hear from company executives, industry experts, and financial analysts across the two-day event. The dual-track format allows for deep dives into each sector, while also highlighting the synergies between them. For example, AI-driven drug discovery is a growing trend, where computational power accelerates the identification of potential therapies, blurring the lines between life sciences and tech infrastructure. Similarly, biotech companies are increasingly reliant on advanced computing and data analytics, making the relationship between the two sectors more intertwined than ever.
The conference’s location in New York City, at The Westin New York Grand Central, provides a convenient hub for investors from around the globe. Registration is now open, and interested parties can sign up through the official conference page at https://moodycapital.com/conference/.
The event is hosted by Moody Capital Solutions, a firm known for its focus on disruptive growth and life sciences. The conference is part of a broader effort to equip investors with the knowledge needed to navigate these complex sectors. InvestorWire, a specialized communications platform, is supporting the event’s promotion. InvestorWire is part of the Dynamic Brand Portfolio within IBN, which provides a range of services including press release syndication, editorial distribution to over 5,000 outlets, and social media amplification. For more information about InvestorWire, visit https://www.InvestorWire.com.
The conference comes at a time when market participants are closely watching the small- and mid-cap space for opportunities. With large-cap stocks often dominating headlines, the nimble, innovative companies in these sectors can offer unique growth potential. However, they also carry higher risks, making in-person due diligence and direct engagement with management teams crucial. Moody Capital’s conference aims to bridge that gap, providing a platform for meaningful dialogue and discovery.
As the September dates approach, industry observers anticipate a robust turnout, given the heightened interest in these sectors. The conference’s dual focus is a acknowledgment of the evolving investment landscape, where traditional sector boundaries are blurring and new opportunities emerge at the intersection of technology, healthcare, and energy. For investors looking to stay ahead of the curve, this event represents a timely and relevant opportunity to gain insights that could inform their strategies for the coming years.
In summary, the 2026 Disruptive Growth & Life Sciences Conference is poised to be a key event for investors seeking to understand and capitalize on the forces reshaping the market. By uniting two of the most dynamic sectors under one roof, Moody Capital is facilitating conversations that could lead to the next wave of investment success.
